The Journal of Headache and Pain: From Utopian Heresy to Scientific Leadership in the Field

Serving the Global Headache and Pain Community
The Journal of Headache and Pain: From Utopian Heresy to Scientific Leadership in the Field
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The years when the founding of The Journal of Headache and Pain was considered a heretical endeavor are now long gone. What began as a utopian vision has evolved into established leadership in the field, reinforced by a consecutive four-year track record of excellence and anchored in solid resilience.  

Before delving into the analytical review of the 2024 metrics, I would like to highlight just two institutional milestones that have quietly left their mark on this journey: The first was a 2007 Consensus that secured the Official WHO Logo, and the second was the 2018 Position Paper developed in Official Collaboration with the European Medicines Agency.  

Other highly successful strategic initiatives have included the Collections, the inclusive recruitment of young talents beyond traditional scientific networks, which gave rise to the Juniors’ Vision Projects Part 1 and Part 2, and the 2025 Early Career Research Mentorship Program. The latter, through outstanding papers, exhausted its annual quota of 10 waivers for winners within just a few weeks.  Applications for the 2026 Edition open early next year.

Unfortunately, it must also be noted that the anticipated coverage of global unmet needs with innovative drugs has fallen far short of expectations, failing to reduce the disease burden as demonstrated in various Global Burden of Diseases Studies.  

One last key point before discussing the metrics is surpassing the threshold of 50% new authors compared to historical ones.  

And now, the detailed analysis of the 2024 metrics:   

2-Year Impact Factor  (Clarivate)

The 2024 2-year impact factor is 7.9, an increase from a score of 7.3 in 2023.

The new impact factor is based on 9027 citations made in 2024 to 309 citable items published in 2022 and 2023. For comparison, the 2023 IF  was based on 8,166 citations made in 2023 to 292 citable items published in 2021 and 2022.

The Impact Factor without self-citations is 6.6.

TJHP now stands at 14/285 in the category Clinical Neurology (19/277 in 2023), and in Neurosciences it is now ranked 21/314 (previously 26/310).  This is the highest ranking in both categories that the journal has held. In both categories, TJHP is also the highest ranked journal with a specific focus on headache.

5-year Impact Factor (Clarivate)

The 2024 5-year impact factor is 7.4, down slightly from 7.7 in 2023. The 5-year impact factor is an indicator of the sustained impact of journal publications. For 2024, the score is calculated from citations made in 2024 of articles published by the journal between 2019 and 2023.

Immediacy Index (Clarivate)

The 2024 Immediacy Index is 1.7, down slightly from 1.9 in 2023. The Immediacy Index indicates the number of citations to articles published within the same year, and so demonstrates how quickly recently published research is cited. This year, the score is calculated from citations made in 2024 of articles published by TJHP in 2024.  

Journal Citation Indicator (JCI) (Clarivate)

Additionally, the Journal Citation Indicator (JCI) for TJHP has increased to 1.99 for 2024, from 1.92 in 2023. The JCI calculates the average Category Normalized Citation Impact of citable items published by the journal over a recent three-year period, with the category average score 1.0.

EigenFactor (Clarivate)

TJHP has a 2024 EigenFactor score of 0.01105 (an increase from 0.01072 in 2023). The EigenFactor calculates the number of journal article citations over 5 years, factoring in the impact factor of the citing journal and excluding self-citations.

CiteScore (Scopus)

The CiteScore for TJHP has decreased, from 11.8 in 2023, to 11.1 in 2024. The journal dropped in both categories for the 2024 CiteScore, from 4/136 in 2023 to 5/139 in 2024 in the category Anesthesiology and Pain Medicine, and from 27/400 in 2023 to 30/400 in 2024 in the category Neurology (clinical).

SCImago Scientific Journal Ranking (SJR) (Scopus)

The SCImago SJR for TJHP increased to 2.066 in 2024, from 1.791 in 2023. This places the journal in the top quartile for the categories Anesthesiology and Pain Medicine, Neurology (clinical), and Medicine (miscellaneous). The  SCImago SJR calculates the number of journal article citations within a year (2024), of articles posted over 3 years (2021-2023), factoring in the prestige of the citing journal.

 Usage

Article downloads for TJHP decreased in 2024, from just above 3 million in 2023 to 2.7 million in 2024.

We acknowledge the credit for this success to all those who have served and continue to serve on the various Boards over time. We acknowledge the dedication of all the referees who have worked to enhance the quality of the scientific contributions from the many authors. We acknowledge the merit of the numerous Authors who have chosen this challenging stage to make their scientific voices heard. We acknowledge the support of Scientific Societies connected to TJHP by a well-established partnership. We acknowledge the top-tier professionalism of our Publisher, Springer Nature. We even acknowledge the murmured scorn for the ones who see—and fail to act— (Dante’s Inferno, Canto III) to whom we have always spared but a fleeting glance.

Let us continue our stroll down this Via Condotti of headaches, admiring the exquisite, finely crafted works that will continue to grace its glittering storefronts.

Paolo Martelletti, on behalf of all Editors 2000-2025

 

 

 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Wei Wang
about 1 year ago

Wishing TJHP continued success under the leadership of Professor Paolo. With united efforts, may we overcome the challenge of headaches together.@Paolo

Go to the profile of Abouch Krymchantowski
about 1 year ago

Excellent, Professor! Indeed, a very courageous initiative, which is applauded Today. I wish Brazil could be more like this, and with less envy and sabotage. 

Follow the Topic

Biomedical Research
Life Sciences > Health Sciences > Biomedical Research
Neuroscience
Life Sciences > Biological Sciences > Neuroscience
Internal Medicine
Life Sciences > Health Sciences > Clinical Medicine > Internal Medicine

Related Collections

With Collections, you can get published faster and increase your visibility.

Focus India

Headache disorders, especially migraine, constitute a major neurological health challenge and are increasingly recognized as leading contributors to disability worldwide. Their impact extends beyond episodic pain, influencing cognitive performance, emotional well-being, and overall quality of life. India carries a substantial share of the global migraine burden, yet remains affected by significant gaps in awareness, diagnosis, access to specialist care, and research output. Although global research has clarified many aspects of headache pathophysiology, the expression of these disorders varies across populations due to genetic, environmental, cultural, and healthcare access factors in the Indian context.

Migraine, in particular, demonstrates substantial heterogeneity in symptom patterns, triggers, and response to therapy, underscoring the need for population specific data. India’s vast and heterogeneous population offers a unique opportunity to generate locally relevant epidemiological, clinical, and translational insights. In many regions, underdiagnosis and inadequate treatment remain persistent problems, often compounded by stigma and limited awareness. Understanding the burden of headache disorders within specific communities in India is essential for designing effective public health strategies, improving diagnostic pathways, and tailoring management approaches. Moreover, the chronic nature of recurrent headaches places a significant economic burden on individuals and healthcare systems through lost productivity and frequent medical consultations. Through this Collection, we aim to stimulate nationally driven research, foster collaboration across institutions and care settings, and strengthen India’s contribution to global headache and brain health science.

Topics of interest include but are not limited to:

  • Epidemiology of migraine in India
  • Management strategies of migraine in Indian patients
  • Cultural perceptions of tension-type headache
  • Treatment approaches for cluster headaches
  • Trigeminal autonomic cephalalgias in diverse populations
  • Chronic daily headache management strategies
  • Impact of lifestyle factors on headache prevalence
  • Public health initiatives for headache awareness
  • Innovations in headache research methodologies

We welcome submissions from author groups with their main affiliated institution in India. Cross-international authorship groups are welcome to submit their work to The Journal of Headache and Pain outside of this Collection.

This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Dec 01, 2026

Focus China

Headache disorders, particularly migraine, represent a significant and growing public health concern with a major impact on disability and quality of life. While research has advanced our global understanding, the specific manifestations, burdens, and management challenges of these conditions within unique populations require dedicated attention. In China, factors such as vast geographical disparities, rapid urbanization, diverse ethnicities, and a unique healthcare system structure present distinctive opportunities and challenges in the recognition, diagnosis, and treatment of headache disorders.

This thematic Collection, “Focus China”, aims to illuminate the landscape of headache medicine in China by exploring epidemiological patterns, clinical characteristics, healthcare access, traditional and integrative medicine approaches, and the socio-economic impact of headache disorders across the country.

We invite submissions of original research, systematic and narrative reviews, editorials, rapid reviews, and commentaries on topics including, but not limited to:

• The epidemiology, burden, and clinical features of migraine and other headache disorders in specific Chinese populations and regions.

• Advanced neuroimaging studies identifying unique endophenotypes, structural and functional brain alterations, and biomarkers of headache disorders in the Chinese cohort.

• Insights into the pathophysiology of headache disorders from a Chinese perspective, including research on epigenetics, neuron-glia interactions, and multi-omics.

• Studies on the integration of Traditional Chinese Medicine (TCM) with conventional headache management.

• Unique cultural, environmental, and genetic factors influencing headache disorders in China.

• The development and validation of diagnostic tools for the Chinese population.

This Collection provides a dedicated platform for researchers and clinicians primarily affiliated with Chinese institutions to share their insights and contribute to the global knowledge of headache science while addressing the specific needs of their region. By fostering collaboration and knowledge exchange, “Focus China” aims to drive meaningful advancements in headache research and patient care across China.

Therefore, the Collection welcomes submissions from author groups with their main affiliated institution in China. Cross-international authorship groups are welcome to submit their work to The Journal of Headache and Pain outside of this Collection.

This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Oct 13, 2026